Dan Xu Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

11/2022	Single-cell RNA sequencing to explore composition of peripheral blood NK cells in patients with chronic myeloid leukemia in treatment-free remission.
3/2019	[Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib].
1/2019	A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy.
5/2016	Association between the concentration of imatinib in bone marrow mononuclear cells, mutation status of ABCB1 and therapeutic response in patients with chronic myelogenous leukemia.
2/2015	[Clinical analysis of acute heart failure's risk factor for chronic myelogenous leukemia patient during the early stage of allogeneic hematopoietic stem cell transplantation].
8/2014	[Correlation between point mutation in ABL kinase and clinical outcome of chronic myeloid leukemia patients].
10/2013	[Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase].
1/2013	Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation.
3/2012	[Study on imatinib trough concentration, efficacy and their relation in chronic myelocytic leukemia].
2/2012	Imatinib and bortezomib induce the expression and distribution of anaphase-promoting complex adaptor protein Cdh1 in blast crisis of chronic myeloid leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan Xu Research Topics

Disease

85	Neoplasms (Cancer) 05/2024 - 11/2004
67	Inflammation (Inflammations) 04/2024 - 01/2009
41	Infections 04/2024 - 04/2004
35	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 06/2007
26	Fibrosis (Cirrhosis) 01/2024 - 08/2011
18	COVID-19 01/2024 - 01/2020
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2022 - 12/2003
16	Obesity 01/2024 - 09/2011
16	Leukemia 07/2018 - 04/2003
16	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2013 - 11/2003
14	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2006
14	Pneumonia (Pneumonitis) 05/2023 - 04/2004
13	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2004
11	Glioma (Gliomas) 04/2024 - 01/2018
11	Pain (Aches) 02/2024 - 09/2016
11	Carcinogenesis 01/2021 - 12/2008
10	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2024 - 11/2011
10	Non-alcoholic Fatty Liver Disease 01/2024 - 09/2011
10	Body Weight (Weight, Body) 12/2023 - 06/2012
9	Sepsis (Septicemia) 04/2024 - 01/2017
9	Hypoxia (Hypoxemia) 01/2024 - 01/2013
9	Ischemia 01/2024 - 01/2007
9	Hypersensitivity (Allergy) 11/2022 - 01/2013
8	Necrosis 12/2023 - 04/2007
8	Wounds and Injuries (Trauma) 12/2023 - 07/2008
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2023 - 04/2002
8	Insulin Resistance 01/2023 - 03/2013
8	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2004
8	Carcinoma (Carcinomatosis) 07/2022 - 09/2007
7	Hemorrhage 12/2023 - 01/2009
7	Hyperplasia 12/2023 - 06/2009
7	Ischemic Stroke 12/2023 - 03/2010
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2023 - 09/2012
7	Acute Lung Injury 07/2022 - 09/2012
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2012
7	Stroke (Strokes) 11/2021 - 03/2010
6	Pancreatitis 04/2024 - 12/2013
6	Melanoma (Melanoma, Malignant) 02/2024 - 08/2012
6	Asthma (Bronchial Asthma) 01/2024 - 11/2007
6	Lung Injury 03/2023 - 03/2009
6	Reperfusion Injury 12/2022 - 01/2007
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2022 - 09/2012
6	Osteoporosis 05/2022 - 11/2012
6	Liver Cirrhosis (Hepatic Cirrhosis) 11/2018 - 04/2007
5	Bacterial Infections (Bacterial Infection) 01/2024 - 07/2019
5	Hypercholesterolemia 12/2023 - 09/2014
5	Atherosclerosis 12/2023 - 01/2018
5	Liver Diseases (Liver Disease) 03/2023 - 10/2020
5	Fetal Weight 12/2022 - 04/2012
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2022 - 11/2019

Drug/Important Bio-Agent (IBA)

65	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2004
36	CytokinesIBA 03/2024 - 04/2009
28	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2011
23	Messenger RNA (mRNA)IBA 01/2023 - 04/2004
19	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2011
19	SmokeIBA 01/2023 - 03/2010
18	Therapeutic UsesIBA 05/2024 - 11/2002
15	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 12/2010
13	LipidsIBA 03/2024 - 02/2014
13	EnzymesIBA 01/2024 - 03/2006
12	Caffeine (No Doz)FDA LinkGeneric 12/2023 - 01/2012
11	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2012
11	VaccinesIBA 03/2024 - 02/2014
11	AntioxidantsIBA 01/2023 - 03/2008
11	Peptides (Polypeptides)IBA 01/2021 - 07/2003
11	Imatinib Mesylate (Gleevec)FDA Link 05/2016 - 12/2003
10	LipopolysaccharidesIBA 01/2024 - 01/2009
10	GlucocorticoidsIBA 01/2024 - 01/2018
10	EndosulfanIBA 03/2023 - 03/2016
10	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2015
9	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 11/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2005
8	CholesterolIBA 03/2024 - 04/2007
8	CateninsIBA 01/2024 - 11/2014
8	InflammasomesIBA 11/2023 - 01/2018
8	Oxygen (Dioxygen)IBA 10/2023 - 12/2010
8	Long Noncoding RNAIBA 03/2023 - 11/2011
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2005
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 04/2002
7	Retinaldehyde (Retinal)IBA 03/2024 - 09/2004
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2024 - 01/2018
7	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 09/2009
6	Nicotine FDA Link 10/2022 - 05/2013
6	AntigensIBA 01/2022 - 01/2008
6	C-Reactive ProteinIBA 03/2021 - 01/2015
6	Phosphotransferases (Kinase)IBA 11/2020 - 03/2006
6	Caspase 3 (Caspase-3)IBA 11/2020 - 03/2005
6	MucinsIBA 10/2016 - 06/2007
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2013 - 11/2003
5	Monoclonal AntibodiesIBA 04/2024 - 10/2006
5	COVID-19 VaccinesIBA 03/2024 - 01/2021
5	LigandsIBA 12/2023 - 03/2005
5	oxidized low density lipoproteinIBA 11/2023 - 09/2012

Therapy/Procedure

71	Therapeutics 05/2024 - 09/2003
21	Transplantation 05/2024 - 11/2002
19	Hematopoietic Stem Cell Transplantation 03/2019 - 04/2003
11	Drug Therapy (Chemotherapy) 04/2023 - 11/2009
10	Immunotherapy 03/2024 - 01/2019
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024 - 03/2008
8	Aftercare (After-Treatment) 12/2023 - 09/2007